Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
33.47
-0.18 (-0.53%)
At close: Jun 27, 2025, 4:00 PM
33.47
0.00 (0.00%)
After-hours: Jun 27, 2025, 4:34 PM EDT
Agios Pharmaceuticals Market Cap
Agios Pharmaceuticals has a market cap or net worth of $1.94 billion as of June 27, 2025. Its market cap has decreased by -27.69% in one year.
Market Cap
1.94B
Enterprise Value
566.73M
1-Year Change
-27.69%
Ranking
Category
Stock Price
$33.47
Market Cap Chart
Since July 24, 2013, Agios Pharmaceuticals's market cap has increased from $919.00M to $1.94B, an increase of 110.93%. That is a compound annual growth rate of 6.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 1.95B | 3.99% |
| Dec 31, 2024 | 1.87B | 50.56% |
| Dec 29, 2023 | 1.24B | -19.33% |
| Dec 30, 2022 | 1.54B | -13.57% |
| Dec 31, 2021 | 1.79B | -40.52% |
| Dec 31, 2020 | 3.00B | 6.73% |
| Dec 31, 2019 | 2.81B | 4.81% |
| Dec 31, 2018 | 2.68B | -3.76% |
| Dec 29, 2017 | 2.79B | 58.97% |
| Dec 30, 2016 | 1.75B | -28.25% |
| Dec 31, 2015 | 2.44B | -37.12% |
| Dec 31, 2014 | 3.89B | 420.55% |
| Dec 31, 2013 | 746.50M | -18.77% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |